Norgine is a pharmaceutical company specialized in gastrointestinal and hepatology therapeutic areas. They develop, manufacture, and market innovative medicines that aim to improve the quality of life for patients.
Norgine was established in 1906 as a small pharmaceutical company in the Netherlands.
In the early days, Norgine focused on the production and distribution of essential medicines.
Over the years, Norgine expanded its presence globally and became a leading player in the gastrointestinal and hepatology therapeutic areas.
In 1998, Norgine acquired Merrell Dow UK, strengthening its product portfolio.
In 2002, Norgine acquired Delta Medical Limited, enhancing its healthcare offerings.
In 2012, Norgine established its presence in the United States by acquiring Merus Labs International Inc.
Throughout its history, Norgine has been committed to research and development, aiming to provide innovative solutions for unmet medical needs.
Takeda Pharmaceutical Company is a global pharmaceutical company with a focus on research and development in various therapeutic areas. They have a strong presence in the gastrointestinal and hepatology fields.
AbbVie is a pharmaceutical company that specializes in the research and development of innovative therapies in several therapeutic areas, including gastroenterology.
AstraZeneca is a global biopharmaceutical company that focuses on developing drugs for various medical conditions, including gastrointestinal disorders.
MOVIPREP® is a bowel cleansing solution used before medical procedures or surgeries to cleanse the colon and improve the visibility of the gastrointestinal tract.
PLENVU® is a bowel cleansing solution that provides a split-dose regimen and improves colon cleansing for patients undergoing colonoscopies.
XIFAXAN® is an antibiotic used to treat certain gastrointestinal infections caused by bacteria. It is indicated for conditions like traveler's diarrhea and irritable bowel syndrome with diarrhea.
Norgine specializes in the gastrointestinal and hepatology therapeutic areas.
Some of Norgine's main products include MOVIPREP®, PLENVU®, and XIFAXAN®.
Norgine's competitors include Takeda Pharmaceutical Company, AbbVie, and AstraZeneca.
Norgine was established in 1906.
Norgine's bowel cleansing solutions are used before medical procedures or surgeries to cleanse the colon and improve visibility of the gastrointestinal tract.